Improving Sepsis Diagnosis with Biomarkers
Author Information
Author(s): Gisela D. De La Rosa, Marta L. Valencia, Clara M. Arango, Carlos I. Gomez, Alex Garcia, Sigifredo Ospina, Susana Osorno, Adriana Henao, Fabián A. Jaimes
Primary Institution: Universidad de Antioquia
Hypothesis
Can three biological markers improve the diagnosis of sepsis in patients with presumptive infections?
Conclusion
The study aims to evaluate the accuracy of three biomarkers for diagnosing sepsis, which could lead to better patient outcomes.
Supporting Evidence
- Sepsis is a major global health issue with high mortality rates.
- Early treatment of sepsis is linked to better clinical outcomes.
- Current diagnostic methods for sepsis lack a reliable gold standard.
Takeaway
Doctors are trying to find better ways to tell if someone has sepsis by looking at certain markers in their blood.
Methodology
Cross-sectional study assessing the diagnostic characteristics of D-dimer, C-reactive protein, and Procalcitonin in sepsis.
Limitations
The study relies on the absence of a gold standard for sepsis diagnosis, which complicates the evaluation of test accuracy.
Participant Demographics
Patients aged 18 and older with presumptive infections admitted to the emergency room.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website